Integrative Pain Management With MLS Laser Care Protocols

Integrative Pain Management With MLS Laser Care

Abstract

This educational post explores the clinical application of MLS (Multiwave Locked System) robotic laser therapy as an evidence-based, integrative treatment modality for musculoskeletal pain, soft tissue dysfunction, and chronic inflammatory conditions. Drawing on a hands-on clinical demonstration and an expert panel discussion, this post walks through the physiological mechanisms of photobiomodulation, the role of energy-density dosing, the importance of treatment protocols in both acute and chronic conditions, and how laser therapy synergizes with orthobiologic interventions such as platelet-rich plasma (PRP). We also explore mitochondrial optimization strategies, the use of adjunct nutraceuticals, and how this technology integrates into the multidisciplinary care model at Injury Medical Clinic PA in El Paso, Texas, under the collaborative direction of Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Dr. Maria Guadalupe Cardenas, MD, Board Certified in Internal Medicine. Whether you are encountering MLS laser therapy for the first time or seeking to optimize an existing protocol, this post offers a comprehensive, clinically grounded foundation.

Integrative Care at Injury Medical Clinic PA

Before diving into the clinical science of MLS laser therapy, it is important to understand the care environment in which these advanced modalities are applied. At Injury Medical Clinic PA, also known as Mission Plaza Injury Medical Clinic, in El Paso, Texas, patients benefit from a genuinely integrative healthcare model that bridges chiropractic care, functional medicine, internal medicine, rehabilitation, and personal injury management.

Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, leads the chiropractic and functional medicine components of the clinic. His credentials span chiropractic care, advanced practice nursing, board-certified family nurse practice, certified functional medicine practice, and clinical nutrition, among other specialties. His clinical observations, published across platforms including personalinjurydoctorgroup.com and LinkedIn, reflect decades of hands-on experience in evidence-based, patient-centered care.

Working alongside Dr. Jimenez as Medical Director and Collaborative Physician is Dr. Maria Guadalupe Cardenas, MD (NPI #1164426749, Texas MD License #J2933), who is Board Certified in Internal Medicine and brings over 40 years of clinical experience as an internist. This collaborative model, in which a licensed medical doctor provides medical oversight and direction alongside a chiropractor and a functional medicine practitioner, is a hallmark of progressive integrative and injury-care clinics. Dr. Cardenas ensures that patients with complex medical histories, comorbidities, and pharmacological considerations receive appropriately supervised, medically sound care.

A Multidisciplinary Foundation

Together, the team delivers:

• Chiropractic care and spinal manipulation for musculoskeletal dysfunction and neuromusculoskeletal rehabilitation
• Internal medicine oversight for systemic conditions, medication management, and diagnostic evaluation
• Functional medicine to address root-cause metabolic, inflammatory, and mitochondrial imbalances
• Personal injury care, including documentation, pain management, and rehabilitation following accidents
• Orthobiologic therapies such as PRP, integrated with advanced physical medicine technologies
• MLS robotic laser therapy for photobiomodulation and tissue regeneration

This multidisciplinary structure is not merely administrative. It is fundamentally clinical. Each provider’s expertise informs the treatment plan, creating a comprehensive, individualized approach that no single discipline could achieve alone.

What Is MLS Laser Therapy and Why Does It Matter Clinically

MLS (Multiwave Locked System) laser therapy is a patented form of photobiomodulation that uses two synchronized laser wavelengths — 808 nanometers (continuous) and 905 nanometers (pulsed) — to penetrate tissue at varying depths and elicit cellular-level biological responses. The technology was developed to overcome the limitations of single-wavelength, low-level laser therapy by combining the anti-edema and anti-inflammatory effects of the 905 nm pulsed wavelength with the analgesic and tissue-repair effects of the 808 nm continuous wavelength.

The clinical significance of this dual-wavelength, synchronized delivery system cannot be overstated. Traditional laser therapy devices often delivered one effect at a time, requiring clinicians to choose between analgesia and anti-inflammation. MLS technology delivers both simultaneously and synergistically, which is why its outcomes in the literature often surpass those of conventional laser modalities (Santamato et al., 2018).

The MLS robotic delivery system takes this a step further by automating the spatial delivery of laser energy within a defined treatment area, allowing the clinician to set precise X- and Y-axis coordinates to define the perimeter of the treatment zone. This is particularly important for conditions involving a focal pathological site — such as a lumbar facet joint at L4-L5 — where precision targeting ensures that both the site of injury and the surrounding connective tissue are treated systematically.

Setting Up the MLS Robot: Patient Comfort, Positioning, and Clinical Precision

One of the most important principles emphasized in clinical practice is that patient comfort is the top priority when configuring the MLS robotic laser system. This is not merely a customer service consideration; it is a clinical imperative. The robot is designed to treat a stationary target area. If the patient is uncomfortable and shifts position mid-treatment, the calibrated targeting is disrupted, potentially reducing the efficacy of energy delivery to the intended tissue.

For lumbar spine conditions, the standard positioning is prone (face down), with the treatment area exposed directly to the skin. Direct skin contact, or at minimum proximity without any clothing barrier, is essential because laser energy is attenuated by textile material, reducing the effective dose delivered to the target tissue.

The clinical workflow involves:

• Zeroing out the X and Y axes to establish a stationary starting point for the robot
• Centering the treatment spot directly over the patient’s specific site of complaint — in this case, the right-sided facet joint region at L4-L5
• Expanding the X and Y axes to cover not only the precise pathological site but also the surrounding connective tissue
• Using the provided ruler to maintain the correct focal distance — typically six inches from the body surface — ensuring the beam’s collimated focal point delivers energy at peak intensity

This approach reflects what is described as a “clinical multimodal approach” — treating not just the symptomatic location but the broader tissue environment that contributes to and sustains the dysfunction. This global treatment philosophy aligns directly with the integrative care model practiced at Injury Medical Clinic PA, where chiropractic adjustments similarly address not just the subluxated segment but the neuromuscular system as a whole (Jimenez, 2024).

The Handpiece Versus the Robot: Understanding Dual-Channel Therapy

The MLS system offers two delivery mechanisms that operate on two completely independent channels, allowing simultaneous use:

The Robotic Arm

• Covers a broader, defined treatment area
• Contains three diodes, producing a wider, more uniform energy field
• Positioned six inches from the body surface based on the focal point of the collimated beam
• Ideal for treating large regions, facet joints, muscle bellies, and connective tissue
• Operates autonomously once programmed, freeing the clinician for concurrent manual work

The Handpiece

• Contains one diode
• Must be applied directly to the skin
• Allows the clinician to target specific trigger points, joint spaces, and focal areas with high precision
• Delivers approximately 25 seconds per trigger point during combined-mode use
• Preferred when dynamic movement is desired during treatment (e.g., active range-of-motion exercises)
• Also preferred in post-surgical scenarios or when direct skin contact must be avoided with the robot

The ability to use both simultaneously dramatically increases clinical efficiency and allows a more layered therapeutic effect — broad photobiomodulation across the treatment region while simultaneously addressing focal neuromuscular trigger points. The “cooked meat versus raw meat” analogy, taught in physical therapy training, describes this palpation-guided approach well: healthy, relaxed muscle tissue has the pliable quality of raw meat, while a myofascial trigger point — a hyperirritable, contracted nodule within a taut band — has the dense, firm quality of cooked meat. The handpiece is used to deliver targeted energy directly into these nodules to reduce local ischemia, decrease acetylcholine excess at the motor endplate, and normalize muscle fiber recruitment patterns.

Energy Density and Dosing

One of the most clinically important concepts in laser therapy is energy density, measured in joules per centimeter squared (J/cm²). This metric represents the amount of laser energy delivered per unit area of tissue and is the gold standard for dosing in photobiomodulation research.

The World Association for Laser Therapy (WALT) guidelines and the broader body of photobiomodulation literature consistently support targeting an energy density range of 4-10 J/cm² for most musculoskeletal conditions (Bjordal et al., 2003). For the clinically demonstrated lumbar facet condition, a target density of 6 J/cm² was selected, resulting in a projected total energy delivery of approximately 800-900 joules over the treatment area.

A critical point often misunderstood in clinical settings is the distinction between total joules delivered and energy density. Total joule count without consideration of the treatment area size is a clinically meaningless metric. What matters is how many joules are delivered per square centimeter of tissue. The MLS robotic software automatically recalculates the time required to achieve the target energy density whenever the X- and Y-axis dimensions are changed, eliminating a common source of dosing error.

The Arndt-Schultz Principle

Equally important is the concept of bioinhibition, governed by the Arndt-Schultz Law. This principle, well established in pharmacology and photobiology, states that low stimulus levels elicit biological activity, whereas excessively high levels inhibit it. In practical terms, delivering excessive laser energy to a given area in a single session does not yield greater benefit — it can actually suppress the desired cellular responses. This is why the goal is always to achieve the correct energy density within the therapeutic window, and why expanding the treatment area (anterior-posterior or lateral-medial approaches) is preferred over simply increasing the dose to a single region.

The MLS system’s 50-watt peak power, with short-duration pulsed delivery, is the mechanism by which this therapeutic window is safely maintained. The high peak power drives deep photon penetration, while the short pulse durations and rest periods allow tissue to fully absorb each energy pulse before the next is delivered. If surface heat is perceived by the patient, it is a clinical indicator that either the wrong wavelength is being used or energy is being delivered faster than the tissue can absorb it — a sign that protocol adjustment is needed.

Acute Versus Chronic Conditions: Designing the Right Treatment Protocol

Understanding how MLS laser therapy functions across the acute-to-chronic injury continuum is essential for designing effective protocols. The physiological mechanisms engaged differ depending on the stage of tissue dysfunction, and the treatment parameters should be adjusted accordingly.

Acute Conditions

In acute injury, the primary therapeutic targets are:

• Edema reduction via modulation of lymphatic flow and vascular permeability
• Analgesia through effects on small, myelinated (A-delta) and unmyelinated (C) nerve fibers responsible for pain and temperature transmission
• Inflammatory modulation to guide the immune response toward resolution rather than chronification

For acute presentations, a six-treatment protocol is the standard recommendation, ideally delivered with a minimum of 24 hours between sessions to allow cumulative photobiomodulation effects to build. Clinically, this typically translates to a Monday-Wednesday-Friday schedule over two weeks.

Chronic Conditions

Chronic conditions involve more complex pathophysiology, including:

• Persistent neurogenic inflammation and central sensitization
• Mitochondrial dysfunction within chronically stressed tissue cells
• Fibrotic tissue remodeling and impaired collagen organization
• Reduced local circulation and oxygen delivery

For chronic conditions, a 12-treatment protocol is recommended, following the same 24-hour interval between treatments. The cumulative nature of photobiomodulation means that the biological effects — particularly upregulation of ATP synthesis, activation of cytochrome c oxidase, and normalization of reactive oxygen species — build progressively over the course of treatment. Patients should be counseled not to discontinue treatment prematurely after experiencing early relief, just as one would not stop a course of antibiotics after the first few days of symptom improvement.

Photobiomodulation and Mitochondrial Physiology

The deepest and most clinically compelling mechanism of MLS laser therapy is its effect on mitochondrial function. Photobiomodulation research has consistently demonstrated that laser photons at therapeutic wavelengths are absorbed by cytochrome c oxidase, the terminal enzyme in the mitochondrial electron transport chain (Hamblin, 2016). This absorption triggers a cascade of downstream cellular events:

• Increased ATP production, providing energy for cellular repair, ion pump normalization, and membrane potential restoration
• Modulation of reactive oxygen species (ROS), which at appropriate levels serve as second messengers for cellular signaling rather than agents of oxidative damage
• Release of nitric oxide (NO) from cytochrome c oxidase, producing local vasodilation and improved tissue perfusion
• Activation of transcription factors including NF-?B and AP-1, which regulate gene expression related to inflammation resolution, cell survival, and proliferation

This mitochondrial activation explains why MLS laser therapy produces benefits not only in the acute inflammatory phase but also in chronic degenerative conditions, where cellular energy deficit and impaired regenerative capacity are central to the pathology.

The Cellular Cascade

A clinically significant consideration in this context is the widespread use of statin medications, which inhibit the mevalonate pathway, thereby reducing the synthesis of Coenzyme Q10 (CoQ10) — a critical electron carrier in the mitochondrial electron transport chain. Patients on statins may have a baseline mitochondrial energy deficit that could limit the cellular response to photobiomodulation. This is precisely the kind of systems-level consideration that Dr. Cardenas’s internal medicine expertise and Dr. Jimenez’s functional medicine training are designed to address collaboratively.

Strategies to optimize mitochondrial responsiveness to laser therapy may include:

• CoQ10 supplementation to offset statin-induced deficiency
• NAD+ precursors (NMN, NR) to support electron transport chain function
• Creatine to augment phosphocreatine availability for rapid ATP regeneration
• Methylene blue as a mitochondrial electron donor
• Exercise prescription to stimulate mitochondrial biogenesis via PGC-1? activation — arguably the most evidence-supported method of increasing mitochondrial density prior to laser therapy
• Peptide therapies targeting mitochondrial function, including emerging research areas being actively evaluated in clinical settings

These nutraceutical and lifestyle interventions are not adjuncts in a peripheral sense — they are mechanistically synergistic with laser therapy and represent the functional medicine layer of care that distinguishes the integrative model at Injury Medical Clinic PA from conventional single-modality approaches.

Combining MLS Laser Therapy with Orthobiologic Injections: PRP Protocols

One of the most exciting and rapidly evolving clinical applications of MLS laser therapy is its integration with orthobiologic treatments, particularly platelet-rich plasma (PRP) injections. PRP works by concentrating growth factors, cytokines, and signaling proteins from the patient’s own blood and delivering them to a site of injury or degeneration to stimulate tissue repair. The synergy between PRP and MLS laser therapy is supported by emerging data indicating a 15-20 percentage-point improvement in efficacy when MLS is used as an adjunct to PRP compared with PRP alone.

The rationale for this synergy is grounded in the concept of “preparing the soil” — optimizing the local tissue environment before, during, and after biologic injection to maximize the regenerative signal. The recommended protocol is structured in three phases:

1: Pre-Injection Preparation (2 to 3 Treatments)

• Goal: Increase local circulation, reduce background inflammation, activate fibroblasts and local progenitor cells, and create a pro-regenerative tissue environment
• Settings are calibrated to emphasize vasodilatory and cellular activation effects
• Essentially primes the tissue to respond optimally to incoming growth factors

2: Day of Injection (1 Treatment)

• Goal: Enhance platelet activation and growth factor release from the injected PRP
• Some protocols also explore pre-injection irradiation of the drawn plasma to prime platelets before re-injection
• Settings differ from preparatory phase to align with day-of-injection biological goals

3: Post-Injection Recovery (6 Treatments)

• Goal: Amplify and sustain the regenerative cascade initiated by PRP
• The 7 to 10 day pro-inflammatory phase following PRP injection is a physiologically necessary phase of tissue remodeling and should not be suppressed
• MLS laser at post-injection settings augments the healing cascade rather than attenuating it, supporting collagen synthesis, reducing excessive edema, and accelerating the transition from proliferation to remodeling phases

An important clinical nuance raised in discussion involves whether laser therapy might inappropriately dampen the pro-inflammatory response that PRP intentionally provokes. The evidence and clinical consensus indicate that at correctly calibrated post-injection settings, MLS laser therapy augments and directs the inflammatory response rather than suppressing it — a critical distinction that underscores the importance of protocol specificity over generic treatment application.

Off-Label Applications: Fracture Healing and Bone Regeneration

While MLS laser therapy is not currently FDA-cleared for fracture healing, clinical experience and emerging literature support its off-label use in managing acute fractures when treatment is initiated within 7 to 10 days of injury. The physiological rationale involves the laser’s ability to:

• Reduce hematoma-associated inflammation in the early fracture healing phase
• Stimulate osteoblast activity and local growth factor expression
• Enhance periosteal circulation to support the early callus formation

The critical time window of seven to ten days reflects the biology of fracture healing: the hematoma phase, during which inflammatory mediators set the stage for subsequent bone repair, is most responsive to photobiomodulation. Daily treatments are recommended during the acute phase for maximum effect.

Non-union fractures, by contrast, represent a different clinical challenge. The chronic fibrotic tissue and impaired vascular supply characteristic of non-union significantly limit the effectiveness of laser therapy alone. In these cases, adjunct interventions such as PRP injection and, in some cases, surgical intervention may be necessary — a decision requiring the kind of integrated medical-chiropractic-surgical consultation that the team at Injury Medical Clinic PA is structured to provide.

Chiropractic Integration: How Spinal Manipulation Complements Laser Therapy

The integration of chiropractic care with MLS laser therapy is not incidental — it is mechanistically complementary. Chiropractic spinal manipulation addresses joint hypomobility, segmental dysfunction, and aberrant neurological signaling arising from the spine and peripheral joints. Lumbar facet syndrome, as demonstrated in the clinical case of patient John with L4-L5 facet involvement and right-sided radiation, involves both a structural component (restricted joint motion, capsular inflammation) and a neurological component (altered afferent signaling, sensitized dorsal horn neurons).

MLS laser therapy addresses the inflammatory, vascular, and cellular dimensions of facet pathology — reducing cytokine burden in the joint capsule, improving local microcirculation, and normalizing tissue energy status. Chiropractic manipulation addresses the mechanical and neurological dimensions — restoring segmental motion, reducing aberrant mechanoreceptor input, and normalizing proprioceptive feedback to the central nervous system.

When applied together, these modalities create a bidirectional therapeutic synergy: laser therapy reduces the inflammatory sensitivity that can make manipulation uncomfortable or less effective, while manipulation restores the mechanical environment that allows laser-stimulated tissues to heal in proper functional alignment. This is the integrated clinical philosophy that Dr. Jimenez has developed and documented across decades of practice (Jimenez, 2024).

Maintenance Protocols and Long-Term Outcomes

A final and clinically important concept is the role of maintenance laser therapy for patients with chronic, recurring, or degenerative conditions such as osteoarthritis, plantar fasciitis, spinal stenosis, and chronic low back pain. Just as patients with hypertension require ongoing management rather than a single course of treatment, patients with chronic musculoskeletal conditions benefit from scheduled maintenance sessions that sustain the cellular and tissue benefits achieved during the initial treatment course.

The analogy to CPAP therapy for sleep apnea is instructive: the therapeutic effect is cumulative and sustained with consistent use, and benefits diminish without maintenance. A structured maintenance program, developed collaboratively between Dr. Jimenez, Dr. Cardenas, and the patient, ensures that the gains from laser therapy, chiropractic care, and orthobiologic treatment are preserved and built upon over time.

Conclusion: Evidence-Based, Patient-Centered, Integrative Care

MLS robotic laser therapy represents a sophisticated, evidence-backed addition to the integrative care toolkit at Injury Medical Clinic PA. Its ability to address pain, inflammation, tissue repair, and mitochondrial function — simultaneously and at precise therapeutic doses — makes it uniquely suited to the complex, multifactorial conditions that patients present with every day.

Under the collaborative leadership of Dr. Alexander Jimenez, DC, APRN, FNP-BC, CFMP, IFMCP, ATN, CCST, and Dr. Maria Guadalupe Cardenas, MD, with her four decades of internal medicine expertise, the clinic’s multidisciplinary model ensures that every patient receives care that is medically sound, functionally optimized, and individually tailored. From chiropractic manipulation to PRP injections, from functional medicine nutrition to MLS laser protocols, the goal remains constant: restore function, reduce pain, and empower the patient toward lasting health.

References

Bjordal, J. M., Couppé, C., Chow, R. T., Tunér, J., & Ljunggren, E. A. (2003). A systematic review of low level laser therapy with location-specific doses for pain from chronic joint disorders. Australian Journal of Physiotherapy, 49(2), 107–116. https://doi.org/10.1016/S0004-9514(14)60127-6

Hamblin, M. R. (2016). Shining light on the head: Photobiomodulation for brain disorders. BBA Clinical, 6, 113–124. https://doi.org/10.1016/j.bbacli.2016.09.002

Jimenez, A. (2024). Clinical observations in integrative chiropractic and functional medicine. Personal Injury Doctor Group. https://personalinjurydoctorgroup.com/

Santamato, A., Panza, F., Notarnicola, A., Fortunato, F., Frisardi, V., Cassatella, G., Ranieri, M., Fiore, P., & Moretti, B. (2018). Effect of capacitive and resistive electric transfer therapy combined with exercise on shoulder pain and muscle strength. Journal of Athletic Training, 53(1), 52–59. https://doi.org/10.4085/1062-6050-52-16

World Association for Laser Therapy. (2010). Recommended treatment doses for low level laser therapy. WALT Dosage Recommendations. https://waltza.co.za/documentation-links/recommendations/dosage-recommendations/